Concepedia

Dominic L. Li

DL

Statistics

Publications

8

Citations

458

H-Index

8

Active since

1988

Affiliations

Eli Lilly (United States)(Current)

Dominic L. Li is an author at Eli Lilly (United States) specializing in pharmacology, neuropharmacology, and neuroscience.

Publications per year

1988–2017

8

Publications

8

Kainate GluR5 receptor subtype mediates the nociceptive response to formalin in the rat

Rosa Maria A. Simmons, Dominic L. Li, Ken H. Hoo et al. · Neuropharmacology · 1998 · 172 citations

, , +14

Endocannabinoids Activate Transient Receptor Potential Vanilloid 1 Receptors to Reduce Hyperdopaminergia-Related Hyperactivity: Therapeutic Implications

Eleni T. Tzavara, Dominic L. Li, Larissa Moutsimilli et al. · Biological Psychiatry · 2005 · 139 citations

, , +14

3-Aryl-1,2-diacetamidopropane Derivatives as Novel and Potent NK-1 Receptor Antagonists

Philip A. Hipskind, J. Jeffry Howbert, Robert F. Bruns et al. · Journal of Medicinal Chemistry · 1996 · 48 citations · Full text

, , +14

Corticotropin-releasing factor (CRF) or CRF binding-protein ligand inhibitor administration suppresses food intake in mice and elevates body temperature in rats

Stephen C. Heinrichs, Dominic L. Li, Smriti Iyengar · Brain Research · 2001 · 34 citations

, , +15

Broad spectrum efficacy with LY2969822, an oral prodrug of metabotropic glutamate 2/3 receptor agonist LY2934747, in rodent pain models

Michael P. Johnson, Mark Muhlhauser, Eric S. Nisenbaum et al. · British Journal of Pharmacology · 2017 · 22 citations · Full text

, , +17

1–5 of 8